COMMUNIQUÉS West-GlobeNewswire

The American Health Council Physician Board Welcomes Indrani Hightower, MD

06/12/2017 - 15:19

NEW YORK, Dec. 06, 2017 (GLOBE NEWSWIRE) -- The American Health Council is proud to recognize Indrani Sen Hightower, MD as an affiliate of its Physician Board. She has spent the last two years as a Neurologist at the [...]

Immuron to Present at RedChip’s Global Online Growth Conference

06/12/2017 - 15:04

MELBOURNE, Australia, Dec. 06, 2017 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ: IMRN ) (the “Company”) wishes to advise investors that CEO Dr Jerry Kanellos is scheduled to present at RedChip’s Global Online [...]

BioEnterprise Announces New Executive Briefing Series

06/12/2017 - 15:00

CLEVELAND, Dec. 06, 2017 (GLOBE NEWSWIRE) -- Eighty experts from across the country gathered at the Global Center for Health Innovation (Global Center) yesterday to tackle the challenges and potential benefits of [...]

Minerva Neurosciences Announces Enrollment of First Patient in Phase 2b Trial of Seltorexant (MIN-202) in Patients With Insomnia Disorder

06/12/2017 - 14:30

WALTHAM, Mass., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV ), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]

Easton Pharmaceuticals & Partner BMV Medica Announce Delivery and Launch of AmnioSense (AL-Sense) in Mexico; Delivery Date for Purchase Order From Windsor Pharmaceuticals for Central America

06/12/2017 - 14:00

TORONTO, ON, Dec. 06, 2017 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC: EAPH ) and its JV partner, BMV Medica SA de CV, announces product delivery and launch of its licensed AmnioSense (AL-Sense) product from [...]

PositiveID Commences Production of Next Generation Caregiver Thermometer with Bluetooth Capability

06/12/2017 - 14:00

DELRAY BEACH, Fla., Dec. 06, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTC:PSID), a life sciences company focused on detection and diagnostics, is excited to announce that its Thermomedics subsidiary has [...]

Tetraphase Pharmaceuticals to Present at BMO Prescriptions for Success in Healthcare Conference 2017

06/12/2017 - 14:00

WATERTOWN, Mass., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ) a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant [...]

Inovio Pharmaceuticals Appoints Wendy Yarno To its Board of Directors

06/12/2017 - 14:00

PLYMOUTH MEETING, Pa., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced that Wendy Yarno has been elected to the company's Board of Directors. Wendy Yarno has over 25 years [...]

Cellectar Announces Expansion of Relapsed/Refractory Multiple Myeloma Cohort in Phase 2 Trial of CLR 131

06/12/2017 - 14:00

MADISON, Wis., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment [...]

TearLab Prices $3.0 Million Registered Direct Offering

06/12/2017 - 13:49

SAN DIEGO, Dec. 06, 2017 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB:TEAR) (TSX: TLB ) (“TearLab” or the “Company”), today announced the pricing of a registered direct offering of 6,818,182 units at a purchase price [...]

Oncolix, Inc., Announces Submission of Application for Listing on OTC-QB

06/12/2017 - 13:30

HOUSTON, Dec. 06, 2017 (GLOBE NEWSWIRE) -- Oncolix, Inc., (OTC PINK:ONCX) announced today that following the appointment of the second independent member of the Board of Directors the Company has fulfilled the [...]

Tower One Builds 5 Towers in November

06/12/2017 - 13:30

VANCOUVER, British Columbia, Dec. 06, 2017 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) has received a construction update from Argentina, which [...]

Geron to Host Analyst and Investor Meeting and Webcast on December 19, 2017

06/12/2017 - 13:30

MENLO PARK, Calif., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN ) today announced that the company’s analyst and investor meeting to discuss imetelstat clinical data will take place in New York, N. [...]

Summit Therapeutics plc : 3rd Quarter Results

06/12/2017 - 13:01

Summit Therapeutics plc ('Summit', the 'Company' or the 'Group') SUMMIT THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER AND NINE MONTHS ENDED 31 OCTOBER 2017 AND OPERATIONAL PROGRESS Oxford, UK, 6 December [...]

Summit Therapeutics Reports Financial Results for the Third Quarter and Nine Months Ended 31 October 2017 and Operational Progress

06/12/2017 - 13:00

OXFORD, United Kingdom, Dec. 06, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM)(NASDAQ: SMMT ), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy (‘DMD’) and C. [...]

Axsome Therapeutics Announces Closing of $9.5 Million Registered Direct Offering

06/12/2017 - 13:00

NEW YORK, Dec. 06, 2017 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]

Editas Medicine, Inc., Announces Pricing of $50 Million Offering of Common Stock

06/12/2017 - 13:00

CAMBRIDGE, Mass., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today announced the pricing of an underwritten offering of 1,970,000 shares of its common [...]

Madrigal’s MGL-3196 Achieves Primary Endpoint in Patients with Biopsy-proven Non-alcoholic Steatohepatitis (NASH) in Phase 2 Clinical Trial

06/12/2017 - 12:55

-- Statistically significant improvement in the relative decrease in liver fat in patients treated with MGL-3196 compared with placebo, determined by magnetic resonance imaging-estimated proton density fat fraction (MRI [...]

Interim results of first-ever global survey show people with type 2 diabetes underestimate their cardiovascular risk

06/12/2017 - 09:01

Globally, cardiovascular disease (CVD) is the most common cause of death in people with type 2 diabetes 1 1 in 3 respondents considered themselves to be at low risk of (CVD) 2 1 in 6 respondents had never discussed type [...]